Clinical Trial Update: Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a cardioplegia solution in children undergoing cardiac surgery for congenital heart disease has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Cardioplegia solution

Snippet

Sponsor: Dr. F. Köhler Chemie GmbH | Conditions: Congenital Heart Malformations | Phase 2 | Status: SUSPENDED